These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2859544)

  • 1. Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice.
    Zetler G
    Neuropharmacology; 1985 Mar; 24(3):251-9. PubMed ID: 2859544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine sensitizes mice for apomorphine-induced stereotypic gnawing: antagonism by neuroleptics and cholecystokinin-like peptides.
    Zetler G
    Eur J Pharmacol; 1985 May; 111(3):309-18. PubMed ID: 2862047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
    Zetler G
    Eur J Pharmacol; 1983 Oct; 94(3-4):261-70. PubMed ID: 6140174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antistereotype effects of ceruletide and some neuroleptics differentiated by interactions with clonazepam, muscimol, scopolamine and clonidine.
    Zetler G
    Neuropharmacology; 1986 Nov; 25(11):1213-20. PubMed ID: 2879254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A behavioral pharmacological study on CCK-8 related peptides in mice.
    Moroji T; Hagino Y
    Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.
    Zetler G
    Neuropharmacology; 1983 Jun; 22(6):757-66. PubMed ID: 6310434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of ceruletide analogues.
    Zetler G
    Peptides; 1981; 2 Suppl 2():65-9. PubMed ID: 6283499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
    Zetler G
    Eur J Pharmacol; 1984 Jul; 102(2):333-40. PubMed ID: 6090162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
    Zetler G
    Neuropharmacology; 1982 Aug; 21(8):795-801. PubMed ID: 6289160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol.
    Zetler G
    Neuropharmacology; 1981 Mar; 20(3):277-83. PubMed ID: 6267504
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on motor behaviour, hexobarbital-induced sleep and harman-induced convulsions.
    Zetler G
    Peptides; 1982; 3(4):701-4. PubMed ID: 6291014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine separates the antinociceptive effects of cholecystokinin octapeptide and ceruletide from those of morphine.
    Zetler G
    Eur J Pharmacol; 1983 Aug; 92(1-2):151-4. PubMed ID: 6313385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
    Van Ree JM; Gaffori O; De Wied D
    Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV; Arnt J; Hyttel J; Svendsen O
    Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ceruletide and cholecystokinin octapeptide on eating in mice. Interactions with naloxone and the enkephalin analogue, FK 33-824.
    Zetler G; Mörsdorf KH
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):209-13. PubMed ID: 6328330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on isolated intestinal preparations and gallbladders of guinea pigs and mice.
    Zetler G
    Peptides; 1984; 5(4):729-36. PubMed ID: 6093075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological differentiation of dopamine D-1 and D-2 antagonists after single and repeated administration.
    Christensen AV; Arnt J; Svendsen O
    Psychopharmacology Suppl; 1985; 2():182-90. PubMed ID: 2860659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice.
    Christensen AV; Moller Nielsen I
    Psychopharmacologia; 1974 Jan; 34(2):119-26. PubMed ID: 4856369
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term effect of teflutixol on apomorphine-induced stereotypy and vomiting in dogs.
    Svendsen O
    Eur J Pharmacol; 1979 Feb; 53(4):387-90. PubMed ID: 570504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.